Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 in Patients With Non-Alcoholic Steatohepatitis (NASH)

NCT00666016 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Alcoholic Steatohepatitis (NASH)

Interventions

DRUG: TRO19622
DRUG: Placebo

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]